Flow Cytometers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report Download FREE Resources

Published: June 28, 2024 Report Code: GDME1770EPD-ST

Select Item

Flow Cytometers Pipeline Market Report Overview

Flow cytometers are an electronic detection apparatus used in a technique for counting and examining microscopic particles, such as cells and chromosomes, by suspending them in a stream of fluid. The flow cytometers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The US

·       Europe

·       China

·       Japan
Key Regulatory Paths ·       510(k)

·       CE-IVD

·       NMPA

·       Ninsho
Leading Companies ·       Acousys Biodevices Inc

·       American Association for the Advancement of Science

·       Becton Dickinson and Co

·       Beyond Blood Diagnostics Ltd

·       Boston University

·       Cytoastra LLC
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Flow Cytometers Pipeline Market Segmentation by Territories

A few of the key territories within the flow cytometers pipeline market are the US, Europe, China, and Japan. As of June 2024, the US accounts for the highest number of pipeline products.

Flow Cytometers Pipeline Market Analysis by Territories, 2024 (%)

Flow Cytometers Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Flow Cytometers Pipeline Market

Download a Free Report Sample

Flow Cytometers Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the flow cytometers pipeline products market are 510(k), CE-IVD, NMPA, and Ninsho. As of June 2024, 510(k) is the most followed pathway for pipeline products in the flow cytometers market.

Flow Cytometers Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Flow Cytometers Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Flow Cytometers Pipeline Market

Download a Free Report Sample

Flow Cytometers Pipeline Market – Competitive Landscape

A few of the key companies associated with the flow cytometers pipeline market are Acousys Biodevices Inc., American Association for the Advancement of Science, Becton Dickinson and Co., Beyond Blood Diagnostics Ltd., Boston University, and Cytoastra LLC among others.

Becton Dickinson and Co.: Becton Dickinson and Co (BD), headquartered in New Jersey, the US, is a medical technology company, which manufactures and sells medical devices, reagents, and instruments. Its major products include syringes and pen needles, intravenous catheters, infusion pumps, and disposable automated medication and supply management systems among others. BD offers its products for life science researchers, healthcare institutions, clinical laboratories, the pharmaceutical industry, and the general public.

Beyond Blood Inc.: Beyond Blood Diagnostics Ltd is a medical equipment company engaged in the research, development, and marketing of medical home test kits used for identifying various types of blood cells based on their unique biophysical properties. The company is headquartered in London, Greater London, the UK.

Flow Cytometers Pipeline Market Analysis by Companies, 2024

Flow Cytometers Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Flow Cytometers Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Flow Cytometers Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • China
  • Japan

Flow Cytometers Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE-IVD
  • NMPA
  • Ninsho

Scope

This report provides:

  • Extensive coverage of the flow cytometers under development.

  • Details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of flow cytometers and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of flow cytometers under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Acousys Biodevices Inc
American Association for the Advancement of Science
Becton Dickinson and Co
Beyond Blood Diagnostics Ltd
Boston University
Cytoastra LLC
Eta Diagnostics Inc
Immune IQ
Kinetic River Corp
Microsensor Labs LLC
NanoCellect Biomedical, Inc.
North Carolina State University
Standard BioTools Inc
Sysmex Corp
The University of Manchester
Ubiquitin Biotechnology (Zhejiang) Co Ltd
University of California
University of California Los Angeles
University of Colorado
University of New Mexico
US Naval Research Laboratory
VeraPulse LLC

Table of Contents

  • 1. 1 Table of Contents

    • 1.1. List of Tables

    • 1.2. List of Figures

  • 2. Introduction

    • 2.1. Flow Cytometers Overview

  • 3. Products under Development

    • 3.1. Flow Cytometers – Pipeline Products by Stage of Development

    • 3.2. Flow Cytometers – Pipeline Products by Territory

    • 3.3. Flow Cytometers – Pipeline Products by Regulatory Path

    • 3.4. Flow Cytometers – Pipeline Products by Estimated Approval Date

    • 3.5. Flow Cytometers – Ongoing Clinical Trials

  • 4. Flow Cytometers – Pipeline Products under Development by Companies

    • 4.1. Flow Cytometers Companies – Pipeline Products by Stage of Development

    • 4.2. Flow Cytometers – Pipeline Products by Stage of Development

  • 5. Flow Cytometers Companies and Product Overview

    • 5.1. Acousys Biodevices Inc. Company Overview

      • 5.1.1. Acousys Biodevices Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2. American Association for the Advancement of Science Company Overview

      • 5.2.1. American Association for the Advancement of Science Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3. Becton Dickinson and Co Company Overview

      • 5.3.1. Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4. Beyond Blood Diagnostics Ltd Company Overview

      • 5.4.1. Beyond Blood Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5. Boston University Company Overview

      • 5.5.1. Boston University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6. Cytoastra LLC Company Overview

      • 5.6.1. Cytoastra LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7. Eta Diagnostics Inc Company Overview

      • 5.7.1. Eta Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8. Immune IQ Company Overview

      • 5.8.1. Immune IQ Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9. Kinetic River Corp Company Overview

      • 5.9.1. Kinetic River Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10. Microsensor Labs LLC Company Overview

      • 5.10.1. Microsensor Labs LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11. NanoCellect Biomedical, Inc. Company Overview

      • 5.11.1. NanoCellect Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12. North Carolina State University Company Overview

      • 5.12.1. North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13. Standard BioTools Inc Company Overview

      • 5.13.1. Standard BioTools Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14. Sysmex Corp Company Overview

      • 5.14.1. Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15. The University of Manchester Company Overview

      • 5.15.1. The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16. Ubiquitin Biotechnology (Zhejiang) Co Ltd Company Overview

      • 5.16.1. Ubiquitin Biotechnology (Zhejiang) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17. The University of California Company Overview

      • 5.17.1. University of California Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18. University of California Los Angeles Company Overview

      • 5.18.1. University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19. University of Colorado Company Overview

      • 5.19.1. University of Colorado Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20. University of New Mexico Company Overview

      • 5.20.1. University of New Mexico Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21. US Naval Research Laboratory Company Overview

      • 5.21.1. US Naval Research Laboratory Pipeline Products & Ongoing Clinical Trials Overview

    • 5.22. VeraPulse LLC Company Overview

      • 5.22.1. VeraPulse LLC Pipeline Products & Ongoing Clinical Trials Overview

  • 6. Flow Cytometers- Recent Developments

    • 6.1. May 30, 2024: Novacyt Announces Final Results

    • 6.2. May 28, 2024: 1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek Biosciences Approved for Clinical Use in China

    • 6.3. May 20, 2024: Cytek Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

    • 6.4. May 20, 2024: Novacyt Notice of Results and AGM

    • 6.5. May 13, 2024: Rima Alameddine Named President of BD Peripheral Intervention

    • 6.6. Apr 30, 2024: Cytek Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe

    • 6.7. Mar 07, 2024: Cytek Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions

    • 6.8. Feb 27, 2024: Dave Hickey Announces Intent to Retire from BD

    • 6.9. Feb 15, 2024: Stephen Agostini Named UCLA’s Vice Chancellor and Chief Financial Officer

    • 6.10. Feb 06, 2024: Beckman Coulter Diagnostics Appoints Kevin O’Reilly as New President

    • 6.11. Jan 17, 2024: Cytek Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries

    • 6.12. Dec 21, 2023: Cytek Biosciences Introduces the Cytek Orion Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry

    • 6.13. Dec 08, 2023: Beckman Coulter Receives 510(K) Clearance For DxFLEX Flow Cytometer

    • 6.14. Nov 21, 2023: BD Names Dr. Ronald Silverman as Chief Medical Officer

    • 6.15. Nov 14, 2023: BD to Present at the 6th Annual Evercore ISI HealthCONx Conference

    • 6.16. Oct 17, 2023: BD Names Greg Rodetis as Senior Vice President of Investor Relations

    • 6.17. Oct 04, 2023: Boston University Names Melissa L. Gilliam 11th President

    • 6.18. Sep 20, 2023: Cytek Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe

    • 6.19. Sep 14, 2023: Cytek Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry

    • 6.20. Aug 29, 2023: Bio-Rad Launches First StarBright Red Dye and Extends Range of Antibody Markers Conjugated to StarBright Dyes to Enhance Multiplex Flow Cytometry and Research Capabilities

    • 6.21. Aug 23, 2023: BD to Present at Investor Healthcare Conferences

  • 7. Appendix

    • 7.1. Methodology

    • 7.2. About GlobalData

    • 7.3. Contact Us

    • 7.4. Disclaimer

Table

Flow Cytometers – Pipeline Products by Stage of Development 9

Flow Cytometers – Pipeline Products by Territory 10

Flow Cytometers – Pipeline Products by Regulatory Path 11

Flow Cytometers – Pipeline Products by Estimated Approval Date 12

Flow Cytometers – Ongoing Clinical Trials 13

Flow Cytometers Companies – Pipeline Products by Stage of Development 14

Flow Cytometers – Pipeline Products by Stage of Development 15

Acousys Biodevices Inc Pipeline Products & Ongoing Clinical Trials Overview 16

Acousys Photoacoustic Flow Cytometer – Product Status 16

Acousys Photoacoustic Flow Cytometer – Product Description 16

American Association for the Advancement of Science Pipeline Products & Ongoing Clinical Trials Overview 17

CytoPAN – Product Status 17

CytoPAN – Product Description 17

Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 18

BD ClearCount CD4 Analyzer – Product Status 18

BD ClearCount CD4 Analyzer – Product Description 18

Beyond Blood Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

Flow Cytometry Device – Product Status 19

Flow Cytometry Device – Product Description 19

Boston University Pipeline Products & Ongoing Clinical Trials Overview 20

Parallel Microfluidic Flow Cytometer – Product Status 20

Parallel Microfluidic Flow Cytometer – Product Description 20

Cytoastra LLC Pipeline Products & Ongoing Clinical Trials Overview 21

Photoacoustic Flow Cytometry – Malaria – Product Status 21

Photoacoustic Flow Cytometry – Malaria – Product Description 21

Eta Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 22

Parallel Flow Cytometer – Product Status 22

Parallel Flow Cytometer – Product Description 22

Immune IQ Pipeline Products & Ongoing Clinical Trials Overview 23

Immune Reveal – Cancer – Product Status 23

Immune Reveal – Cancer – Product Description 23

Immune Reveal – COVID-19 – Product Status 24

Immune Reveal – COVID-19 – Product Description 24

Immune Reveal – Sepsis – Product Status 24

Immune Reveal – Sepsis – Product Description 25

Kinetic River Corp Pipeline Products & Ongoing Clinical Trials Overview 26

Label-Free Flow Cytometer – Product Status 26

Label-Free Flow Cytometer – Product Description 26

Microsensor Labs LLC Pipeline Products & Ongoing Clinical Trials Overview 27

MagiCyte – Product Status 27

MagiCyte – Product Description 27

NanoCellect Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28

3D-FACS – Product Status 28

3D-FACS – Product Description 28

FlowNostic System – Product Status 29

FlowNostic System – Product Description 29

Lab-On-A-Chip Flow Cytometer – COST Coding – Product Status 29

Lab-On-A-Chip Flow Cytometer – COST Coding – Product Description 30

OncoSorter – Product Status 30

OncoSorter – Product Description 30

North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 31

Thermal Flow Cytometer – Product Status 31

Thermal Flow Cytometer – Product Description 31

Standard BioTools Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Helios System – Product Status 32

Helios System – Product Description 32

Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 33

Immuno-flowFISH – Bone Marrow Cancer – Product Status 33

Immuno-flowFISH – Bone Marrow Cancer – Product Description 33

Immuno-flowFISH Test – Leukaemia – Product Status 34

Immuno-flowFISH Test – Leukaemia – Product Description 34

The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 35

Portable Instrument – Urinary Tract Infections – Product Status 35

Portable Instrument – Urinary Tract Infections – Product Description 35

Ubiquitin Biotechnology (Zhejiang) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

Flow Cytometry Device – Product Status 36

Flow Cytometry Device – Product Description 36

University of California Pipeline Products & Ongoing Clinical Trials Overview 37

Computation Cytometer – Product Status 37

Computation Cytometer – Product Description 37

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 38

Microfluidic Image Cytometry Device – Product Status 38

Microfluidic Image Cytometry Device – Product Description 38

University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 39

Flow Cytometry Device – Product Status 39

Flow Cytometry Device – Product Description 39

University of New Mexico Pipeline Products & Ongoing Clinical Trials Overview 40

Magnecytometer – Product Status 40

Magnecytometer – Product Description 40

US Naval Research Laboratory Pipeline Products & Ongoing Clinical Trials Overview 41

Flow Microflow Cytometer – Product Status 41

Flow Microflow Cytometer – Product Description 41

VeraPulse LLC Pipeline Products & Ongoing Clinical Trials Overview 42

Photoacoustic Flow Cytometry Device – Product Status 42

Photoacoustic Flow Cytometry Device – Product Description 42

VeraPulse LLC – Ongoing Clinical Trials Overview 43

Photoacoustic Flow Cytometry Device – In Vivo Detection of Circulating Clots in Patients With Thromboembolism 44

Glossary 61

Figures

Flow Cytometers – Pipeline Products by Stage of Development 9

Flow Cytometers – Pipeline Products by Territory 10

Flow Cytometers – Pipeline Products by Regulatory Path 11

Flow Cytometers – Pipeline Products by Estimated Approval Date 12

Flow Cytometers – Ongoing Clinical Trials 13

Frequently asked questions

Flow Cytometers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Flow Cytometers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Flow Cytometers reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Flow Cytometers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Flow Cytometers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more